{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:34:27Z","timestamp":1793230467666,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejps.2024.106706","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T22:54:55Z","timestamp":1705618495000},"page":"106706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells"],"prefix":"10.1016","volume":"194","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashaal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-5739","authenticated-orcid":false,"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.ejps.2024.106706_bib0050","doi-asserted-by":"crossref","first-page":"E11138","DOI":"10.1073\/pnas.1801156115","article-title":"Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"14","key":"10.1016\/j.ejps.2024.106706_bib0003","doi-asserted-by":"crossref","first-page":"15632","DOI":"10.1002\/cam4.6123","article-title":"The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients","volume":"12","author":"Bola\u00f1os-Su\u00e1rez","year":"2023","journal-title":"Cancer Med."},{"issue":"19","key":"10.1016\/j.ejps.2024.106706_bib0038","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.3390\/cancers14194797","article-title":"CREPT disarms the inhibitory activity of HDAC1 on oncogene expression to promote tumorigenesis","volume":"14","author":"Cao","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ejps.2024.106706_bib0023","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/ph16050765","article-title":"Alkaloid from Geissospermum sericeum Benth. & Hook.f. ex Miers (Apocynaceae) induce apoptosis by caspase pathway in human gastric cancer cells","volume":"16","author":"Carmo Bastos","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejps.2024.106706_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115022","article-title":"Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells","volume":"247","author":"Di Bello","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2024.106706_bib0006","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/14756366.2022.2148317","article-title":"Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors","volume":"38","author":"Fan","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106706_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.947252","article-title":"Establishment, immunological analysis, and drug prediction of a prognostic signature of ovarian cancer related to histone acetylation","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106706_bib0012","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-1-0716-2788-4_26","article-title":"Cloning strategy for HDAC1\/HDAC2 hybrid protein expression in mammalian cells","volume":"2589","author":"G\u00fcl","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejps.2024.106706_bib0025","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1038\/s41598-023-36555-w","article-title":"SelSA-1, a novel HDAC inhibitor demonstrates enhanced chemotherapeutic potential by redox modulation","volume":"13","author":"Garg","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ejps.2024.106706_bib0027","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/acs.jmedchem.3c00226","article-title":"The zinc-binding group effect: lessons from non-hydroxamic acid vorinostat analogs","volume":"66","author":"Geurs","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2024.106706_bib0035","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1080\/14756366.2022.2121822","article-title":"Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer","volume":"37","author":"Guo","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106706_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114827","article-title":"Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: histone deacetylases inhibitory activity and molecular docking study","volume":"244","author":"Hamdi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejps.2024.106706_bib0008","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13543776.2018.1432596","article-title":"Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011-2016)","volume":"28","author":"Hameed","year":"2018","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.ejps.2024.106706_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2022.104807","article-title":"Proteomics-based trapping with single or multiple inactive mutants reproducibly profiles histone deacetylase 1 substrates","volume":"274","author":"Herath","year":"2023","journal-title":"J. Proteomics."},{"issue":"2","key":"10.1016\/j.ejps.2024.106706_bib0033","first-page":"343","article-title":"Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer","volume":"26","author":"Higashijima","year":"2011","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.ejps.2024.106706_bib0026","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/bph.13414","article-title":"Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling","volume":"173","author":"Kim","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.ejps.2024.106706_bib0005","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.3390\/cancers14184458","article-title":"Review article: immune landscape and immunotherapy options in cervical carcinoma","volume":"14","author":"Kousar","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.ejps.2024.106706_bib0043","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/1062936X.2022.2145353","article-title":"A quantitative structural analysis of AR-42 derivatives as HDAC1 inhibitors for the identification of promising structural contributors","volume":"33","author":"Kundu","year":"2022","journal-title":"SAR. QSAR. Environ. Res."},{"issue":"18","key":"10.1016\/j.ejps.2024.106706_bib0021","doi-asserted-by":"crossref","first-page":"10916","DOI":"10.3390\/ijms231810916","article-title":"A novel L-phenylalanine dipeptide inhibits the growth and metastasis of prostate cancer cells via targeting DUSP1 and TNFSF9","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ejps.2024.106706_bib0028","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3390\/ijms19071939","article-title":"Therapeutic opportunities of targeting histone deacetylase isoforms to eradicate cancer stem cells","volume":"19","author":"Lin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2024.106706_bib0048","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190527","article-title":"The function of histone acetylation in cervical cancer development","volume":"39","author":"Liu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejps.2024.106706_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115585","article-title":"Design, synthesis, activity and molecular dynamics studies of 1,3,4-thiadiazole derivatives as selective allosteric inhibitors of SHP2 for the treatment of cancer","volume":"258","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106706_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106727","article-title":"Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity","volume":"139","author":"Liu","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejps.2024.106706_bib0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12032-023-02058-x","article-title":"Recent advancement of HDAC inhibitors against breast cancer","volume":"40","author":"Mehmood","year":"2023","journal-title":"Med. Oncol."},{"issue":"22","key":"10.1016\/j.ejps.2024.106706_bib0020","doi-asserted-by":"crossref","first-page":"12972","DOI":"10.1093\/nar\/gkaa1121","article-title":"The topology of chromatin-binding domains in the NuRD deacetylase complex","volume":"48","author":"Millard","year":"2020","journal-title":"Nucleic. Acids. Res."},{"issue":"2","key":"10.1016\/j.ejps.2024.106706_bib0034","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.lungcan.2011.02.019","article-title":"Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung","volume":"74","author":"Minamiya","year":"2011","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.ejps.2024.106706_bib0032","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MPA.0b013e31815f2c2a","article-title":"Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation","volume":"36","author":"Miyake","year":"2008","journal-title":"Pancreas"},{"issue":"13","key":"10.1016\/j.ejps.2024.106706_bib0046","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.3390\/molecules27134014","article-title":"HDAC inhibitory and anti-cancer activities of curcumin and curcumin derivative cu17 against human lung cancer A549 cells","volume":"27","author":"Namwan","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ejps.2024.106706_bib0011","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/febs.16683","article-title":"11-Cl-BBQ, a select modulator of AhR-regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27Kip1","volume":"290","author":"Nguyen","year":"2023","journal-title":"FEBS. J."},{"issue":"1","key":"10.1016\/j.ejps.2024.106706_bib0045","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1038\/s41598-023-30144-7","article-title":"PAMAM-G4 protect the N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) and maintain its antiproliferative effects on MCF-7","volume":"13","author":"Ortiz-Morales","year":"2023","journal-title":"Sci Rep."},{"issue":"10","key":"10.1016\/j.ejps.2024.106706_bib0047","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.3390\/molecules27103332","article-title":"Histone deacetylase inhibitory activity and antiproliferative potential of new [6]-Shogaol derivatives","volume":"27","author":"Phaosiri","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejps.2024.106706_bib0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/cancers15010263","article-title":"Towards novel gene and cell therapy approaches for cervical cancer","volume":"15","author":"Polten","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejps.2024.106706_bib0029","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1080\/14756366.2022.2063281","article-title":"Phosphorus containing analogues of SAHA as inhibitors of HDACs","volume":"37","author":"Pun","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2024.106706_bib0002","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ejps.2024.106706_bib0022","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/molecules28031035","article-title":"Galantamine based novel acetylcholinesterase enzyme inhibitors: a molecular modeling design approach","volume":"28","author":"Silva","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ejps.2024.106706_bib0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/07391102.2018.1441072","article-title":"Insights into structural features of HDAC1 and its selectivity inhibition elucidated by molecular dynamic simulation and molecular docking","volume":"37","author":"Sixto-L\u00f3pez","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.ejps.2024.106706_bib0049","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.apsb.2021.07.003","article-title":"Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejps.2024.106706_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.932914","article-title":"Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2024.106706_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.ejps.2024.106706_bib0019","doi-asserted-by":"crossref","first-page":"e10622","DOI":"10.15252\/emmm.201910622","article-title":"HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies","volume":"12","author":"Wu","year":"2020","journal-title":"EMBo Mol. Med."},{"issue":"10","key":"10.1016\/j.ejps.2024.106706_bib0037","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/neuonc\/noaa103","article-title":"Increased activation of HDAC1\/2\/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma","volume":"22","author":"Yang","year":"2020","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.ejps.2024.106706_bib0009","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1007\/s12010-022-04258-z","article-title":"Synthesis of quinoline-2-carboxylic acid aryl ester and its apoptotic action on PC3 prostate cancer cell line","volume":"195","author":"Yang","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"24","key":"10.1016\/j.ejps.2024.106706_bib0040","doi-asserted-by":"crossref","first-page":"21755","DOI":"10.1021\/acsomega.3c01317","article-title":"Histone deacetylase inhibition and autophagy modulation induces a synergistic antiproliferative effect and cell death in cholangiocarcinoma cells","volume":"8","author":"Yenig\u00fcl","year":"2023","journal-title":"ACS. Omega"},{"issue":"3","key":"10.1016\/j.ejps.2024.106706_bib0018","first-page":"3296","article-title":"Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs","volume":"17","author":"Yu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.ejps.2024.106706_bib0036","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41419-022-05040-z","article-title":"SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells","volume":"13","author":"Zeng","year":"2022","journal-title":"Cell Death. Dis."},{"issue":"6","key":"10.1016\/j.ejps.2024.106706_bib0017","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1515\/hsz-2017-0306","article-title":"HDAC1 knockdown inhibits invasion and induces apoptosis in non-small cell lung cancer cells","volume":"399","author":"Zhang","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejps.2024.106706_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105407","article-title":"Discovery of quinazolinyl-containing benzamides derivatives as novel HDAC1 inhibitors with in vitro and in vivo antitumor activities","volume":"117","author":"Zhang","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"19","key":"10.1016\/j.ejps.2024.106706_bib0014","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.2174\/1389557522666220330144151","article-title":"The Zinc-dependent HDACs: non-histone substrates and catalytic deacylation beyond deacetylation","volume":"22","author":"Zheng","year":"2022","journal-title":"Mini. Rev. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejps.2024.106706_bib0010","doi-asserted-by":"crossref","first-page":"14295","DOI":"10.3390\/ijms232214295","article-title":"Synthesis of glycolysis inhibitor PFK15 and Its synergistic action with an approved multikinase antiangiogenic drug on human endothelial cell migration and proliferation","volume":"23","author":"Zlack\u00e1","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.ejps.2024.106706_bib0016","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3390\/cells11152380","article-title":"Quantitative acetylomics uncover acetylation-mediated pathway changes following histone deacetylase inhibition in anaplastic large cell lymphoma","volume":"11","author":"Zrim\u0161ek","year":"2022","journal-title":"Cells"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:10:25Z","timestamp":1760530225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":50,"alternative-id":["S0928098724000174"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106706","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106706"}}